Description
This procedure involves the analysis of specific gene sequences in the JAK2 gene, focusing on exons 12 and 13. It is particularly relevant for diagnosing myeloproliferative neoplasms in patients who do not have the JAK2 V617F mutation, aiding in the understanding of their condition and guiding treatment options.
—
—
No crosswalks found.
No alternates found.
No codes found here.
We make no claims to ownership of the coding systems referenced on this platform. Codes and descriptions are produced from claims and chargemaster data available through the CMS-9915-F Transparency in Coverage Final Rule and via state or federal datasets. This service is provided solely as a reference to encourage use of these codes in our chargemaster review and automated billing tools, so that healthcare professionals can understand and correctly report these codes in their claims.